Robotic, organ-sparing surgery shows high efficacy for gastric tumors

Minimally invasive, ultrasound-guided robotic resections for gastric gastrointestinal stromal tumors (GISTs) demonstrate remarkable safety and efficacy. A study of 46 patients, primarily with challenging tumor locations, revealed no intraoperative complications or conversions to open surgery. The approach resulted in less than 5% postoperative morbidity and an impressive median disease-free survival rate of 98% at 36 months. This method significantly minimizes organ sacrifice while achieving optimal oncological outcomes, supporting its use in complex cases.